XERACALM AD
The prevalence of dry skin prone to atopic eczema is 10% for adults1, 20% for children2. Dry skin is accompanied by redness, itching and discomfort. These skin symptoms generally recur over time. To space out episodes of dryness and associated skin discomfort, we recommend the daily use of an emollient skin care product to moisturize and repair the skin barrier. That's why XERACALM AD skin care products are recommended by dermatologists.
- Read more
-
With XERACALM AD, we have formulated skincare products for all conditions and all ages. The I-MODULIA+ complex neutralizes , at the heart of the microbiome, the source of dryness episodes for optimized anti-itching and anti-relapse action.Avène thermal spring water soothes immediately. LIPID:B2, a nutritive complex, replenishes the skin and protects the cutaneous barrier.
Regular use is essential: two applications a day are needed for immediate soothing and long-lasting anti-itching and anti-relapse action.
Action technology
Dr Chris CALLEWAERT
Researcher | Skin microbiome expert
Ghent University, BELGIUM
I-MODULIA+
I-MODULIA+ acts directly on the main virulence factors produced by Staphylococcus aureus, helping to reduce its inflammatory potential. By targeting these molecular triggers, it promotes the bacterium's return to a commensal state, where it coexists harmlessly with the skin microbiome.
This new publication presents the efficacy ofI-MODULIA+, a new combination of active ingredients acting synergistically on the virulence of S. aureus, a key player in atopic dermatitis.
All products in the XERACALM AD range are classified as Emollient Plus. In addition to their moisturizing and lipid-replenishing action, they incorporate I-MODULIA+, a specific postbiotic complex acting on the key biological mechanisms of dry skin with atopic tendencies. This global approach soothes inflammation, reduces itching and durably restores skin comfort.
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.